Philip Karlsson

Short presentation

My PhD is about how bacteria of different species interact to cause urinary tract infections, primarily through biofilms, in intensive care unit patients.

PhD representative in the Research Training Committee (KUF). Until recently, research assistant for the development of new diagnostic approaches in clinical microbiology, Uppsala university hospital, and research visitor at the Marshall Centre for Infectious Diseases Research, Australia.

Keywords

  • antibiotic resistance
  • epidemiology
  • infection biology
  • antibiotic use
  • urinary tract infections
  • clinical bacteriology
  • molecular epidemiology
  • bacterial biofilms

Media

The use of broad-spectrum antibiotics increased drastically in intensive care at the beginning of the Covid-19 pandemic. At first, this helped patients avoid urinary tract infections and seemed to prevent the growth of most bacteria. However, it also contributed to a sharp growth in enterococci, an antibiotic-tolerant group of bacteria, which rendered the treatment of urinary tract infections more difficult.

Antibiotics hindered treatment of urinary tract bacteria

Antibiotic use during coronavirus disease 2019 intensive care unit shape multidrug resistance bacteriuria: A Swedish longitudinal prospective study.

https://www.forskning.se/2023/02/13/bred-antibiotika-forsvarade-behandling-av-urinvagsinfektioner/

Philip Karlsson

Publications

Recent publications

All publications

Articles in journal

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Youtube
Uppsala University on Linkedin